Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Crescita Therapeutics, Inc. CRRTF

Set alert

Price alert · CRRTF

All alert types
0.56 USD 0.00 0.00%

At close · Jun 4

0.5519 Day range 0.5587
0.021 52-week range 0.57305
YTD
+62.46%
1 year
+43.22%
Open
0.5519
Prev close
0.5587
Mkt cap
10.40M
Vol
5.00K
Avg vol
2.20K
EPS
-0.01315
P/E
-42.49
More statistics
Low
0.5519
High
0.5587

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for CRRTF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-0.22 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -96.3×
FY 2016: -1.0×FY 2017: -0.6×FY 2018: 4.1×FY 2019: 10.9×FY 2020: 386×FY 2021: -12.1×FY 2022: 15.6×FY 2023: -3.7×FY 2024: -4.6×FY 2025: -96.3×
FY 2016 5y median -4.6× FY 2025
P/S 0.4×
FY 2016: 4.1×FY 2017: 0.6×FY 2018: 0.6×FY 2019: 0.9×FY 2020: 0.9×FY 2021: 0.8×FY 2022: 0.6×FY 2023: 0.4×FY 2024: 0.6×FY 2025: 0.4×
FY 2016 5y median 0.6× FY 2025
P/B 0.6×
FY 2016: 0.5×FY 2017: 0.6×FY 2018: 0.5×FY 2019: 1.0×FY 2020: 0.7×FY 2021: 0.6×FY 2022: 0.6×FY 2023: 0.4×FY 2024: 0.8×FY 2025: 0.6×
FY 2016 5y median 0.6× FY 2025
P/FCF 12.0×
FY 2016: -0.8×FY 2017: -1.0×FY 2018: -6.0×FY 2019: 4.0×FY 2020: 2.6×FY 2021: -6.9×FY 2022: -10.8×FY 2023: 3.8×FY 2024: 8.1×FY 2025: 12.0×
FY 2016 5y median 3.8× FY 2025
EV/EBITDA 1.4×
FY 2016: -0.9×FY 2017: -0.9×FY 2018: 5.0×FY 2019: 1.9×FY 2020: 0.6×FY 2021: 8.0×FY 2022: 3.4×FY 2023: 1.7×FY 2024: -3.0×FY 2025: 1.4×
FY 2016 5y median 1.7× FY 2025
EV/Sales 0.0×
FY 2016: 3.6×FY 2017: 0.4×FY 2018: 0.3×FY 2019: 0.6×FY 2020: 0.1×FY 2021: 0.3×FY 2022: 0.3×FY 2023: -0.0×FY 2024: 0.2×FY 2025: 0.0×
FY 2016 5y median 0.2× FY 2025
FCF Yield 8.3%
FY 2016: -130.6%FY 2017: -103.5%FY 2018: -16.6%FY 2019: 25.1%FY 2020: 38.7%FY 2021: -14.6%FY 2022: -9.3%FY 2023: 26.4%FY 2024: 12.4%FY 2025: 8.3%
FY 2016 5y median 8.3% FY 2025

Profitability

Gross Margin 49.1%
FY 2016: 33.4%FY 2017: 59.7%FY 2018: 66.7%FY 2019: 74.0%FY 2020: 72.1%FY 2021: 59.7%FY 2022: 56.0%FY 2023: 59.1%FY 2024: 49.1%FY 2025: 49.1%
FY 2016 5y median 56.0% FY 2025
Operating Margin -4.8%
FY 2016: -415.8%FY 2017: -54.7%FY 2018: -0.2%FY 2019: 22.2%FY 2020: 9.9%FY 2021: -4.3%FY 2022: 2.2%FY 2023: -11.2%FY 2024: -16.4%FY 2025: -4.8%
FY 2016 5y median -4.8% FY 2025
Net Margin -0.4%
FY 2016: -426.6%FY 2017: -95.4%FY 2018: 14.4%FY 2019: 8.3%FY 2020: 0.2%FY 2021: -6.6%FY 2022: 3.7%FY 2023: -11.3%FY 2024: -14.0%FY 2025: -0.4%
FY 2016 5y median -6.6% FY 2025
ROE -0.6%
FY 2016: -55.8%FY 2017: -87.5%FY 2018: 12.6%FY 2019: 8.8%FY 2020: 0.2%FY 2021: -5.4%FY 2022: 4.1%FY 2023: -10.6%FY 2024: -17.4%FY 2025: -0.6%
FY 2016 5y median -5.4% FY 2025
ROIC -6.4%
FY 2016: -34.7%FY 2017: -36.8%FY 2018: -0.2%FY 2019: 12.7%FY 2020: 0.5%FY 2021: -3.1%FY 2022: 2.3%FY 2023: -9.7%FY 2024: -19.1%FY 2025: -6.4%
FY 2016 5y median -6.4% FY 2025
ROA -0.5%
FY 2016: -34.7%FY 2017: -50.8%FY 2018: 8.7%FY 2019: 6.9%FY 2020: 0.1%FY 2021: -3.8%FY 2022: 3.0%FY 2023: -8.1%FY 2024: -12.6%FY 2025: -0.5%
FY 2016 5y median -3.8% FY 2025

Growth (YoY)

Revenue 7.8%
FY 2016: 308.9%FY 2017: 242.9%FY 2018: 38.4%FY 2019: 34.3%FY 2020: -30.0%FY 2021: 7.2%FY 2022: 40.3%FY 2023: -25.5%FY 2024: 11.7%FY 2025: 7.8%
FY 2016 FY 2025
Operating Income 68.2%
FY 2016: 5.2%FY 2017: 54.9%FY 2018: 99.4%FY 2019: 13527.0%FY 2020: -68.7%FY 2021: -146.2%FY 2022: 173.6%FY 2023: -469.8%FY 2024: -64.4%FY 2025: 68.2%
FY 2016 FY 2025
EPS (diluted) 96.5%
FY 2016: 13.3%FY 2017: 29.9%FY 2018: 114.6%FY 2019: -31.2%FY 2020: -97.8%FY 2021: -3055.6%FY 2022: 177.3%FY 2023: -338.4%FY 2024: -42.9%FY 2025: 96.5%
FY 2016 FY 2025
Free Cash Flow -52.0%
FY 2016: -34.1%FY 2017: 59.8%FY 2018: 78.4%FY 2019: 413.9%FY 2020: 9.0%FY 2021: -135.0%FY 2022: 35.7%FY 2023: 255.6%FY 2024: -20.7%FY 2025: -52.0%
FY 2016 FY 2025

Financial Health

Current Ratio 3.3×
FY 2016: 3.2×FY 2017: 2.1×FY 2018: 3.0×FY 2019: 3.7×FY 2020: 4.2×FY 2021: 3.0×FY 2022: 3.4×FY 2023: 3.8×FY 2024: 2.8×FY 2025: 3.3×
FY 2016 5y median 3.3× FY 2025
Quick Ratio 2.3×
FY 2016: 2.8×FY 2017: 1.5×FY 2018: 2.5×FY 2019: 2.8×FY 2020: 3.5×FY 2021: 2.3×FY 2022: 2.5×FY 2023: 2.5×FY 2024: 2.0×FY 2025: 2.3×
FY 2016 5y median 2.3× FY 2025
Debt / Equity 0.0×
FY 2016: 0.3×FY 2017: 0.3×FY 2018: 0.2×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.0×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -17.2×
FY 2016: 0.1×FY 2017: 0.5×FY 2018: -3.8×FY 2019: -1.2×FY 2020: -5.8×FY 2021: -14.0×FY 2022: -3.3×FY 2023: 18.1×FY 2024: 6.3×FY 2025: -17.2×
FY 2016 5y median -3.3× FY 2025
Interest Coverage -24.3×
FY 2016: -118×FY 2017: -15.6×FY 2018: -0.1×FY 2019: 7.3×FY 2020: 6.2×FY 2021: -3.0×FY 2022: 3.3×FY 2023: -23.0×FY 2024: -49.5×FY 2025: -24.3×
FY 2016 5y median -23.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31